Central venous catheter infections in AIDS patients receiving daily home therapy for cytomegalovirus disease.

@article{Casado1996CentralVC,
  title={Central venous catheter infections in AIDS patients receiving daily home therapy for cytomegalovirus disease.},
  author={Jos{\'e} Lu{\'i}s Casado and Enrique Navas and A Garc{\'i}a and Antonio Antela and Eva G. Redondo and Jes{\'u}s Fort{\'u}n and Antonio Guerrero},
  journal={QJM : monthly journal of the Association of Physicians},
  year={1996},
  volume={89 9},
  pages={
          695-9
        }
}
  • J. Casado, E. Navas, +4 authors A. Guerrero
  • Published 1 September 1996
  • Medicine, Biology
  • QJM : monthly journal of the Association of Physicians
We studied the infection rate of long-term intravenous access used for daily home treatment of cytomegalovirus (CMV) disease in 61 AIDS patients who had 75 central venous catheters implanted for antiviral maintenance therapy between February 1989 and December 1994. In 39 patients (64%) the risk factor for AIDS was intravenous drug abuse. Sixty-three catheters were Hickman type and 12 were totally implanted ports. The cumulative follow-up time was 19000 catheter-days (52 patient-years), with… 
View on PubMed
academic.oup.com
5 Citations
Highly Influential Citations
1

5 Citations

Citation Type

Citation Type

Central venous catheters in patients with AIDS
TLDR
The experience suggests that home intravenous therapy and previous IDU does not preclude the use of CVCs although further research is needed on reducing the infection-related complications of such therapy.
A critical approach to the pathogenesis, diagnosis, treatment and prevention of catheter-related bloodstream infections and nosocomial endocarditis
TLDR
The frequency of hospitalized patients who undergo some type of intravenous catheterization is very high, and on many occasions this is the main reason for hospital admission, and the rates of bacteremia associated with peripheral catheters were clearly inferior.
Report of ESGNI–001 and ESGNI–002 studies. Bloodstream infections in Europe
TLDR
When EU and non-EU countries were compared there were no significant differences in the clinical data, reported between both groups, and the multivariable analysis showed that the factors remaining independent predictors of mortality were age, severity of underlying diseases and severity of sepsis score.
The K-port concept: Proposal for optimising a fully implantable port system
TLDR
The objective of introducing this new port concept is to reduce the incidence of complications by making alterations to the design, which includes a drop-shaped interior, which opens into the catheter-connecting piece rather like a funnel, the lateral position of the puncture membrane, and the exchangeable catheter connection device.
Infusion of medications via PICC and midline catheters in patients with AIDS

References

SHOWING 1-10 OF 23 REFERENCES
Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.
TLDR
The use of ganciclovir compared to foscarnet in the treatment of AIDS-related CMV disease was not associated with a greater risk of serious catheter-related infection.
Long-term central venous access vs other home therapies: complications in patients with acquired immunodeficiency syndrome.
TLDR
It is concluded that because immunocompromised patients have a high risk of infection, catheter-related sepsis in these patients should be treated by catheter removal and antibiotics.
Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome.
Hickman Catheter Infections in Patients With Malignancies
TLDR
Tentative recommendations for management of the various types of HC infections are outlined, and it is demonstrated that catheter thrombosis was the major risk factor associated with development of catheter infection.
Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients.
Experience with a totally implantable venous access device (Port-A-Cath) in patients with AIDS.
TLDR
A totally implantable venous access device appears to be safe and convenient in (home) infusion therapy in AIDS patients, without risk of additional infection.
Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex.
Totally implanted system for intravenous chemotherapy in patients with cancer.
[Experience with 150 subcutaneous venous reservoirs for venous access and infusion for the treatment of adult patients with oncologic and hematologic disorders and acquired immunodeficiency syndrome].
TLDR
The degree of patient satisfaction and the minimum incidence of serious complications in determined risk groups (neutropenia, acquired immunodeficiency syndrome) demonstrates that subcutaneous venous reservoirs (SVR) constitute an excellent method as a chronic venous access.
Experience with a totally implantable venous access device (Port‐A‐Cath®) in patients with AIDS
TLDR
A totally implantable venous access device appears to be safe and convenient in (home) infusion therapy in AIDS patients, without risk of additional infection.
...
1
2
3
...